hemeonclinx Medical News about advanced ovarian carcinoma; human tissue kallikrein 7

Oncology

Become a Member Today!

Email
Password
Remember me
Forgot your Password?
Invite Code?

Home
General Oncology

For Practicing
Oncologists

Conferences

Jobs

Newsletters

Topics in
Oncology

Alternative Therapies

Anemia/Polycythemia

BMT/SCT

Basic Science/Genetics

Bone/Cartilage

Breast

Carcinogenesis

Coagulation/Bleeding Dz

Colorectal Cancer/Polyps

Dermatologic Oncology

Diagnostics/Radiology

Economics of Medicine

Endocrine Oncology

GI Oncology

Gynecologic Oncology

Head and Neck

Hepatobiliary/Pancreas

Leukemia/Lymphoma

Lung/Thoracic Oncology

Myeloproliferative Dz

Neurologic Oncology

Pain/Palliative Care

Pediatric Heme/Oncology

Pharmacology/Therapy

Popular Press

Renal/Urologic

Side Effects

Soft Tissue/Sarcoma

Transfusion Medicine

Help

Resource Center

RSS News Feeds

Send Newsletter
to a Friend

Sponsor

For Practicing Oncologists

Technology Advances: Volatile Compounds in Skin Cancers May Enable Noninvasive Diagnosis
Dorothy J. Schirf, MD, MDLinx Oncology

Today's Oncology News: Gene Predisposing Neuroblastoma Identified
D Scott Cunningham MD, PhD, MDLinx Oncology

FDA Update: Researchers Enhance Cancer-Fighting Potential of Lycopene
Tracy Hampton, PhD, MDLinx Oncology

See all

advanced ovarian carcinoma; human tissue kallikrein 7

Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website

Human tissue kallikrein 7, a novel biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein expression
Annals of Oncology, 06/27/08

Print

Email This Article

Save in My Library

Free Abstract

Psyrri A et al. - High tumor hk7 protein expression is associated with inferior patient outcome in ovarian cancer. hk7 may represent a promising prognostic factor in ovarian cancer.

--- DIAGNOSTICS/RADIOLOGY TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

Optimal number of radioactive sentinel lymph nodes to remove for accurate axillary staging of breast cancer
Surgery, 08/19/08

Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosis
Mayo Clinic Proceedings, 08/06/08

Pheochromocytoma: Current Approaches and Future Directions
The Oncologist, 08/04/08

...All of Diagnostics/Radiology

Sponsor

--- GYNECOLOGIC ONCOLOGY TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

Quality-of-Life Assessment for Routine Oncology Clinical Practice
The Journal of Supportive Oncology, 06/16/08

Proportion of invasive breast cancer attributable to risk factors modifiable after menopause
American Journal of Epidemiology, 08/19/08

Carboplatin and paclitaxel versus cisplatin, paclitaxel and doxorubicin for first-line chemotherapy of advanced ovarian cancer: a Hellenic Cooperative Oncology Group (HeCOG) study
European Journal of Cancer, 08/13/08

...All of Gynecologic Oncology

Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT

Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology

Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Profession Index

Dentist
Hospital Administrator
Nurse

Medical Students
Nurse Practitioner
Pharma/Drug Marketer

Pharmacist
Physician
Physician Assistants

Article Search

Keyword:

Search:

Published within:

Sort By:
Date Relevance

Sponsor

Sponsor

| | | | | | |

English | Español | Français | Deutsch | 中文 | Руccкий | Norsk | Nederlands | Português | Italiano

©1999-2008 MDLinx, Inc.